Original Source(s)
Related Content
Editorial: Advancing immune research in chronic liver diseases through new approach methodologies
June 30, 2026
FDA Approves Atacicept for IgA Nephropathy
The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.
July 7, 2026
-
3 min
Does TYK2/JAK1 Show Potential in Inflammatory Diseases?
Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.
July 6, 2026
-
3 min